Bioton SA (BIOP)

Currency in PLN
4.19
+0.04(+0.96%)
Closed·
BIOP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.104.20
52 wk Range
3.654.70
Key Statistics
Bid/Ask
4.16 / 4.20
Prev. Close
4.19
Open
4.18
Day's Range
4.1-4.2
52 wk Range
3.65-4.7
Volume
37.32K
Average Volume (3m)
30.39K
1-Year Change
9.6859%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIOP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
27/02/2026
EPS / Forecast
0.02 / --
Revenue / Forecast
64.4M / --
EPS Revisions
Last 90 days

Compare BIOP to Peers and Sector

Metrics to compare
BIOP
Peers
Sector
Relationship
P/E Ratio
107.1x−3.8x−0.5x
PEG Ratio
0.870.030.00
Price/Book
0.6x2.9x2.6x
Price / LTM Sales
1.3x8.1x3.2x
Upside (Analyst Target)
-53.1%48.3%
Fair Value Upside
Unlock−5.4%5.6%Unlock

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.

Employees
363
Market
Poland

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
267.63K0.31%1.11M
Other Institutional Investors
42.77M49.81%177.51M
Public Companies & Retail Investors
42.82M49.87%177.72M
Total
85.86M100.00%356.34M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
DFA Investment Dimensions Group Inc. - Emerging Markets Core Equity 2 Portfolio0.23%193,900812
Dimensional Funds II Plc - Emerging Markets Targeted Value Fund0.03%28,000117

People Also Watch

26.20
MDG
+0.19%
6.5900
MSZ
+2.17%
2.41
PUR1
-0.82%
40.35
SHO1
+0.62%
161.60
DIAP
+2.60%

FAQ

What Is the Bioton SA (Warsaw: BIOP) Share Price Today?

The Bioton SA stock price today is 4.19 PLN.

What Stock Exchange Does Bioton SA (BIOP) Trade On?

Bioton SA is listed and trades on the Warsaw Stock Exchange.

What Is the Ticker (Stock Symbol) for Bioton SA?

The stock symbol (also called a 'ticker') for Bioton SA is "BIOP."

What Is the Current Bioton SA Market Capitalisation?

As of today, Bioton SA (Warsaw: BIOP) market cap is 359.77M PLN.

What Is Bioton SA's (BIOP) Earnings Per Share (TTM)?

The Bioton SA EPS is currently 0.04 (Trailing Twelve Months).

When Is the Next Bioton SA Earnings Date?

Bioton SA's next earnings report will be released on 29/05/2026.

Is BIOP a Buy or Sell From a Technical Analyst Perspective?

Based on today's Bioton SA moving averages and other technical indicators, the daily buy/sell signal for BIOP stock is Strong Buy.

How Many Times Has Bioton SA Stock Split?

Bioton SA has split 3 times. (See the BIOP stock split history page for full effective split date and price information.)

How Many Employees Does Bioton SA Have?

Bioton SA has 363 employees, based on their latest Companies House report.

What is the current trading status of Bioton SA (Warsaw: BIOP)?

As of 07/05/2026, Bioton SA (BIOP) is trading at a share price of 4.19 PLN, with a previous close of 4.19 PLN. The stock has fluctuated within a day range of 4.10 PLN to 4.20 PLN, while its 52-week range spans from 3.65 PLN to 4.70 PLN.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.